Clinical Trial Update: Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma [NA]

View source ↗

Summary

A clinical trial comparing ablative stereotactic radiotherapy (SABR) to brachytherapy for cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: National Institute of Cancerología | Conditions: Uterine Cervical Neoplasm | NA | Status: RECRUITING